Side-by-side comparison of AI visibility scores, market position, and capabilities
Amazon-owned smart home security brand with video doorbells and alarm systems; Neighbors community platform and Ring Protect subscription competing with Google Nest and Arlo cameras.
Ring is Amazon's smart home security brand producing video doorbells, security cameras, smart lighting, and home alarm systems that enable homeowners to monitor their properties remotely through a smartphone app and share video clips with neighbors through the Ring Neighbors community platform. Founded in 2013 by Jamie Siminoff in Santa Monica, California as Doorbot, Ring was acquired by Amazon in 2018 for approximately $1 billion — at the time one of Amazon's largest hardware acquisitions — and has since become a cornerstone of Amazon's smart home ecosystem.\n\nRing's product lineup includes the Video Doorbell series (wired and battery-powered, ranging from basic to Pro models with 4K video), Indoor and Outdoor cameras, Floodlight cameras (combining motion-activated lights with cameras), the Ring Alarm home security system (DIY install with professional monitoring subscription), and the Ring Doorbell Wired for existing doorbell wire installations. Ring Protect plans (subscription) provide cloud video storage, extended warranties, and professional monitoring for the alarm system.\n\nIn 2025, Ring operates within Amazon alongside other smart home brands (Blink, Eero, Amazon Alexa). The company faced significant privacy controversies over its law enforcement data sharing (Ring has provided footage to police through its Neighbors app partnerships), resulting in congressional scrutiny and policy changes. Ring competes with Nest (Google/Alphabet), Arlo, and Eufy (Anker) for home security camera market share. Amazon's 2025 strategy for Ring focuses on deeper Alexa integration (using Ring cameras as Alexa Show screens), expanding Ring Alarm subscriptions for recurring revenue, and growing internationally in markets where smart home security is less penetrated.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.